Upperton Pharma Solutions Announces £15m Investment In New FacilitiesGemma Cann2024-11-28T14:54:01+00:00May 23rd, 2022|BioCity Nottingham, News|
Reach Separations Marks 10th Birthday Milestone With Further Expansion Into EuropeGemma Cann2024-11-28T14:54:18+00:00May 17th, 2022|BioCity Nottingham, News|
Absolute Antibody To Be Featured On “World’s Greatest!…” Television SeriesGemma Cann2024-11-28T14:54:42+00:00May 17th, 2022|News, Wilton Centre|
Amphista Therapeutics Enters Strategic Collaboration With Bristol Myers SquibbGemma Cann2024-11-28T14:54:56+00:00May 4th, 2022|BioCity Glasgow, Investment, News|
Choosing To Challenge Access To Healthcare: I.W.D Interview With Anna MaxwellGemma Cann2024-11-28T14:08:37+00:00November 19th, 2021|Article|
Biotech Spinout Case Study: Kinomica – From Seed To Oversubscribed £3.9m Series A.Gemma Cann2024-11-28T14:08:54+00:00November 19th, 2021|Accelerator, Article|
Two Years Later: We Catch Up With Alex Birks, CEO Of Med-Tech Start-Up Suji BFRGemma Cann2024-11-28T14:19:34+00:00November 19th, 2021|Accelerator, Article|
NanoSyrinx Announces Oversubscribed £6.2m Seed Funding RoundGemma Cann2022-06-30T12:01:24+01:00July 19th, 2021|Investment, News|
Maxwellia’s Lovima Contraceptive Pill Granted MHRA LicenceGemma Cann2022-06-30T12:01:39+01:00July 14th, 2021|News|
Rinri Therapeutics Secures £3.2m Innovate UK FundingGemma Cann2023-09-04T13:12:37+01:00May 13th, 2021|Investment, News|